Clinical trials: Migraine Headache
Migraine
MicroRNA Profile and Erenumab Treatment
Erenumab, a monoclonal antibody acting on the calcitonin gene-related peptide (CGRP) receptor, is an effective and safe migraine-specific preventive drug.
- Trial name
- NCT04659226
- Testing
- Blood sampling for microRNA testing
- Where
- Italy
- Volunteers
- 40 people
- Sponsor
- University of L'Aquila
Migraine Disorders, Headache Disorders
Topical Bimatoprost in the Treatment of Migraine
The study is to assess the effectiveness of topically applied bimatoprost in reducing migraine headache frequency, severity, and duration. It will also assess the effect of topical bimatoprost on quality of life.
- Trial name
- NCT03419715
- Testing
- Bimatoprost Topical Solution, Control
- Where
- 2 sites in United States
- Volunteers
- 70 people
- Sponsor
- Manistee Partners
Episodic Migraine Headache
Craniocervical Flexion Training for Reducing Migraine Headaches and Disability
Migraine, a leading cause of disability globally, necessitates effective interventions beyond pharmacotherapy due to the associated risks.
- Trial name
- NCT06751732
- Testing
- Craniocervical Flexion Training (CCFT), Diaphragm Respiratory Training, Cervical Mobilization and Traction
- Where
- Pakistan
- Volunteers
- 38 people
- Sponsor
- Riphah International University
Workplace Migraine Treatment
Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?
Researchers want to learn about work productivity after treatment of a migraine headache with your usual migraine medication as compared to your work productivity after treatment with Treximet.
- Trial name
- NCT01086358
- Testing
- Triptan, Treximet 85Mg-500Mg Tablet
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- The Cleveland Clinic
Chronic Migraine, Headache
Developing a Mobile Health Pain-Coping Skills Training Program for the Treatment of Chronic Migraine: AIM 4
This ClinicalTrials.gov record pertains only to the clinical trial described below in Aim 4. Aims 1-3 and 5 are described here as background information.
- Trial name
- NCT03465826
- Testing
- PainCOACH Pain Coping Skills Training, Treatment as Usual
- Sponsor
- Wake Forest University Health Sciences
Ménière
Treatment of Meniere's Disease With Migraine Medications
Meniere's disease (MD) is a chronic disease with a variety of fluctuating signs and symptoms, which include vertigo, hearing loss, tinnitus (ringing noise in the ear), aural pressure (feeling of ear fullness), and disequilibrium…
- Trial name
- NCT05582837
- Testing
- nortriptyline + topiramate
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- University of California, Irvine
Migraine Disorders
Transcranial Direct Current Simulation in Chronic Migraine
This study is a pilot, double-blind, placebo-controlled, randomized trial aiming to compare the effects of transcranial direct current stimulation in Chronic Migraine.
- Trial name
- NCT02817139
- Testing
- TDCS
- Where
- Brazil
- Volunteers
- 15 people
- Sponsor
- Federal University of Paraíba
Brain Cancer, Brain Metastases
Single vs Multi-fraction SRS Patients on Immunotherapy
This study is meant to compare different surgical approaches to brain cancer.
- Trial name
- MIGRAINE (NCT04427228)
- Testing
- Radiosurgery Single Treatment, Radiosurgery Three Treatments
- Where
- United States
- Sponsor
- University of Chicago
Migraine Disorders
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
This open-label study will assess the long-term efficacy, safety, and tolerability of onabotulinumtoxinA administered for prophylaxis of headaches in patients with chronic migraine.
- Trial name
- NCT01516892
- Testing
- onabotulinumtoxinA
- Where
- 32 sites in United States, Australia and 1 more
- Volunteers
- 716 people
- Sponsor
- Allergan
Migraine, Headaches
Effect on Migraine Frequency of Combined Anti-oxidant Therapy: The MIGRANT Study.
Migraine affects 15% of Western Australians and is a leading cause of suffering and disability in our community (1,2). Research suggests that inflammation of the brain's coverings (meninges) by nerve cell inflammation and the…
- Trial name
- MIGRANT (NCT02629536)
- Testing
- N-acetyl cysteine 600 mg, VitE 250 IU, VitC 500 mg tablet
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- University of Notre Dame Australia
Migraine With Aura, Migraine Without Aura
Tailored Digital Treatment for Migraine
Background: An individualized internet-based treatment program from a biopsychosocial perspective has been developed within the Västra Götaland region (VGR) with funds from the Innovation Fund.
- Trial name
- NCT05617339
- Testing
- I am (internet approach to migraine)
- Where
- Sweden
- Volunteers
- 200 people
- Sponsor
- Vastra Gotaland Region
Migraine, Laughter
The Effect of Laughter Therapy in Women
Migraine: An episodic disorder consisting of severe headache, usually with photophobia (sensitivity to light), phonophobia (sensitivity to sound), and/or nausea (occasionally vomiting). Migraine is predominantly a female disease.
- Trial name
- NCT05804812
- Testing
- laughter therapy
- Where
- 2 sites in Turkey (Türkiye)
- Volunteers
- 53 people, healthy volunteers welcome
- Sponsor
- Sinop University
Migraine
AMG 334 20160172 Pediatric Migraine PK Study.
AMG 334 20160172 Pediatric Migraine PK Study.
- Trial name
- NCT03499119
- Testing
- AMG 334 Dose 1, AMG 334 Dose 2, AMG 334 Dose 3
- Where
- 14 sites in United States
- Volunteers
- 53 people
- Sponsor
- Amgen
Migraine Disorders
A Study of Lasmiditan in Participants With Migraine
The purpose of this study is to measure how much of the drug gets into the blood stream and how long it takes the body to get rid of it during an acute migraine attack and also during the time between acute migraine attacks.
- Trial name
- NCT03247790
- Testing
- Lasmiditan
- Where
- 3 sites in United States
- Volunteers
- 16 people, healthy volunteers welcome
- Sponsor
- Eli Lilly and Company
Migraine in Children
Tryptophan Metabolites in Pediatric Migraine
Background: Migraine is a common neurological disorder that also has a significant prevalence in children. Although the exact etiology of migraine is unknown, recent studies suggest an association between intestinal flora and…
- Trial name
- NCT05969990
- Testing
- tryptophan metabolites in plasma
- Where
- China
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Qilu Hospital of Shandong University
Chronic Migraine Without Aura, Intractable, Migraine With Typical Aura
Treatment of Chronic Migraine Headaches.
The purpose of the study is assessment of the safety and efficacy of the De-Novo therapy in the treatment of craniofacial neuralgia and migraine headaches.This is an open-label study of simultaneous administration of combination…
- Conditions
- Chronic Migraine Without Aura, Intractable, Migraine With Typical Aura, Migraine Disorders
- Trial name
- Migraine (NCT03220113)
- Testing
- Dexamethasone, Lidocaine, Thiamine cohort
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- Corona Doctors Medical Clinics, Inc.
COVID-19, Long COVID
Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain.
This study aims to verify the efficacy/effectiveness of treatment with transcranial direct current stimulation (TDCS) in patients with Long Covid who experience headaches, migraines, and chronic pain, such as arthralgia and…
- Conditions
- COVID-19, Long COVID, Long Covid19, SARS CoV 2 Infection
- Trial name
- NCT05780450
- Testing
- Transcranial Direct Current Therapy (tDCS)
- Where
- 2 sites in Spain
- Volunteers
- 87 people
- Sponsor
- Fundación Universidad Católica de Valencia San Vicente Mártir
Migraine Disorders, Post-Traumatic Headache
The Role of Osteopathic Manipulation in the the Management of Post-traumatic Migraine
This study evaluates the use of osteopathic manipulation (manual medicine) for migraine headache following traumatic head injury.
- Trial name
- OMT/mTBI (NCT03588364)
- Testing
- Osteopathic Manipulation
- Where
- United States
- Volunteers
- 11 people
- Sponsor
- University of California, San Diego
Migraine
Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?
The purpose of this study is to determine if Rizatriptan, a migraine medication, lowers motion sickness in migraine sufferers.
- Trial name
- NCT00360282
- Testing
- Rizatriptan
- Where
- United States
- Volunteers
- 36 people
- Sponsor
- University of Pittsburgh
Migraine, Head Pain
Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS)
Monoclonal antibodies targeting calcitonin gene-related peptide (mAb-CGRP) have shown efficacy and effectiveness in the treatment of episodic and chronic migraine, however, not all patients respond to them.
- Trial name
- AMARAS (NCT05785988)
- Where
- Spain
- Volunteers
- 600 people
- Sponsor
- Hospital Clínico Universitario de Valladolid